The VATER/VACTERL association is typically defined by the presence of at least three of the following congenital malformations: vertebral anomalies, anal atresia, cardiac malformations, tracheo-esophageal fistula, renal anomalies, and limb abnormalities. The identification of 14 twin pairs with an initial diagnosis of VATER/VACTERL association at our clinical centers led to the performance of a classical twin study. This involved a thorough evaluation of these 14 twin pairs and a further 55 twin pairs identified from a systematic review of the literature. The zygosity, concordance, and malformation status of all 69 twin pairs were evaluated. Twenty-four twin pairs fulfilled the criteria for inclusion in a comparison of the concordance rates between monozygous (MZ) and dizygous (DZ) twin pairs. The pairwise concordance rates were 15% [95% confidence interval (CI) 4-42%] for MZ and 18% (95% CI 5-48%) for DZ twin pairs (P = 0.53). The probandwise concordance rates were 27% (95% CI 11-52%) for MZ and 31% (95% CI 13-58%) for DZ twin pairs (P = 0.40). Although based on a limited number of twin pairs, the findings of the present study are consistent with the low number of familial cases reported to date, and suggest that the role of inherited genetic factors in the majority of VATER/VACTERL cases is limited.
Introduction
The acronym VATER/VACTERL association (MIM #192350) refers to the rare, nonrandom co-occurrence of vertebral defects (V), anorectal malformations (A), cardiac defects (C), tracheoesophageal fistula with or without esophageal atresia (TE), renal malformations (R), and limb defects (L) (Quan and Smith, 1973) . At the time of writing, no diagnostic biomarkers are available, and commonly used clinical diagnosis requires the presence of at least three major component features (CFs) (Quan and Smith, 1973; Czeizel and Ludányi, 1985) .
Population-based epidemiological studies in Europe and the USA have reported a prevalence among infants of one in 10 000 to one in 40 000 (Khoury et al., 1983; Czeizel and Ludányi, 1985; Botto et al., 1997) . The involvement of environmental factors in the etiology of the VATER/ VACTERL association is suggested by both its typically sporadic occurrence (Rittler et al., 1996; Botto et al., 1997) and by reports of discordant monozygous (MZ) twin pairs (Koffler et al., 1978; Cilento et al., 1994; McNamara et al., 1995; Klinger et al., 1997; Cordero et al., 2006; Camacho et al., 2008; Solomon et al., 2011a) . Reported environmental factors include maternal diabetes, uterine vascular pathology, and infertility treatment (Czeizel and Ludányi, 1985; Chan et al., 2002; Ornoy, 2007; Wijers et al., 2010) .
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However, the involvement of genetic factors is suggested by reports of familial occurrence (Fuhrmann et al., 1958; Say et al., 1971; Finer et al., 1978; Auchterlonie and White, 1982; McMullen et al., 1996; Nezerati and McLeod, 1999; Becker et al., 2009; Solomon et al., 2010) , the finding of a significant increase in the prevalence of CFs among the first-degree relatives of affected individuals (Solomon et al., 2010) , and the presence of chromosomal (micro) aberrations in affected individuals (McNeal et al., 1977; Aynaci et al., 1996; Cinti et al., 2001; Walsh et al., 2001; Yamada et al., 2009; Schramm et al., 2011; Solomon et al., 2011b) .
Fourteen twin pairs with an initial diagnosis of VATER/ VACTERL association were identified at three participating clinical centers, and this led us to carry out the first classical twin study for this disorder. This involved a thorough evaluation of these 14 twin pairs and a further 55 twin pairs identified from a systematic review of the literature.
Materials and methods

Participants
All of the 69 twin pairs investigated in the present study were ascertained on the basis of the assignment of an initial diagnosis of a VATER/VACTERL association in at least one twin. All twin pairs were re-evaluated in terms of the precise nature of the major CFs, zygosity, and concordance status, and the presence of additional malformations or disorders beyond the spectrum of the VATER/VACTERL association or known syndromes (e.g. Goldenhar syndrome, Fanconi anemia). The twin analysis was restricted to twin pairs in which at least one twin presented with a minimum of three major CFs of the VATER/VACTERL association. Twin pairs with additional congenital anomalies or disorders that are incompatible with the spectrum of VATER/VACTERL association were excluded from the twin analysis. We also excluded twin pairs with insufficient information on their zygosity status from the twin analysis.
Twin pairs with VATER/VACTERL association identified through the participating centers Six unreported twin pairs with an initial diagnosis of the VATER/VACTERL association were identified from two participating German centers: Bonn (n = 3) and Düsseldorf/Cologne (n = 3). From June 2002 to October 2008, a total of 1130 twin pregnancies were monitored at the Department of Obstetrics and Prenatal Medicine at the University Hospital of Bonn. Similarly, from January 2002 to September 2010, a total of 3742 twin pregnancies in Düsseldorf and Cologne were monitored at 'Praenatal.de', a partnership of private practices for prenatal medicine and genetics. The phenotype of the affected twins was assessed retrospectively from findings at the postnatal clinical examination and documented information on general development. The zygosity status of all same-sex twins who fulfilled the clinical criteria of the VATER/ VACTERL association (n = 3) was determined using the PowerPlex 16 System according to the manufacturer's recommendations (Promega, Madison, Wisconsin, USA).
Four unreported twin pairs were identified within the context of a National Institutes of Health (Bethesda, Maryland, USA) based study on the VATER/VACTERL association. From October 2008 to August 2011, 161 unrelated families with a suspected VATER/VACTERL association were referred or self-referred to the National Human Genome Research Institute at the National Institutes of Health. This number does not include individuals who did not fulfill the criteria for the VATER/ VACTERL association. Of these, 66 unrelated families were seen in person and/or sent samples for genetic research to our laboratory in Bethesda. The zygosity status of all same-sex twins who fulfilled the clinical criteria of the VATER/VACTERL association (n = 3) was determined using the Illumina Omni1-Quad SNP microarray (San Diego, California, USA), which analyzes B1.2 million single nucleotide polymorphisms throughout the human genome.
Four unreported twin pairs were derived from the AGORA project (Aetiologic research into Genetic and Occupational/Environmental Risk Factors for Anomalies in Children), of the Radboud University Nijmegen Medical Centre (RUNMC) in the Netherlands. Since December 2004, the parents of children with a congenital malformation or childhood cancer treated at the pediatric departments of the RUNMC have been asked to participate in the AGORA project, which aims to establish a databank and biobank for these disorders, comprised of questionnaire data and DNA. Diagnostic and twin data were retrieved from the medical records, following anamnestic, physical, and radiographic examinations by experienced clinicians. When unknown, the zygosity status of same-sex twins who fulfilled the clinical criteria of the VATER/VACTERL association (n = 2) was determined using the Applied Biosystems Identifiler kit (Carlsbad, California, USA).
The study was approved by the respective local ethics committees, and appropriate informed consent was obtained from all parents or legal guardians.
Twin pairs with the VATER/VACTERL association identified through a review of the literature A systematic review of the literature was carried out to identify twin pairs with an initial diagnosis of the VATER/VACTERL association. The review included electronic databases such as NCBI (http://www.ncbi.nlm. nih.gov/pubmed), and DIMDI (http://www.dimdi.de/static/de/ index.html) as well as congress reports. The Medical Subject Headings used were VATER, VACTERL association, esophageal atresia, anorectal malformation, congenital heart defect, limb anomalies, renal anomalies, and vertebral anomalies. All reports were reviewed independently by two of the authors (A.C.S. and H.M.R.) to exclude duplicated reports.
Statistics
To compare the concordance rates of the MZ and dizygous (DZ) twin pairs, both pairwise and probandwise concordance rates were calculated. All concordance rates were calculated with the 95% confidence interval (CI), and the difference in the concordance rates between MZ and DZ pairs was tested using the Fisher exact test to assess one-tailed P values (Allen et al., 1967; Risch, 2001) . Probandwise concordance rates can be interpreted as the recurrence risk in the co-twin of an affected individual (Risch, 2001) . Furthermore, we calculated the MZ/DZ ratio for pairwise and probandwise concordance rates.
Results
Twin pairs with the VATER/VACTERL association included in the twin analysis
We identified 14 unreported twin pairs with an initial diagnosis of the VATER/VACTERL association from our three centers and 55 twin pairs from the literature. Reevaluation of the precise nature of CFs of our 14 twin pairs showed that nine twin pairs did not fulfill the conservative clinical criteria for the VATER/VACTERL association (less than three CFs or the presence of additional malformations beyond the spectrum of the VATER/VACTERL association in the affected twin; Supplementary Table 2 ). Of the 55 twin pairs with an initial diagnosis of the VATER/VACTERL association reported in the literature, 38 twin pairs were excluded from the present twin study because of the presence of additional malformations and/or lack of information on phenotype, zygosity, or concordance ( Supplementary  Tables 1 and 2) . In summary, a total of seven twin pairs from our centers and 17 twin pairs from the literature were included in the present twin study (Table 1) .
Twin analysis
Analyses were carried out on two MZ concordant, 11 MZ discordant, two DZ concordant, and nine DZ discordant twin pairs. The pairwise concordance rates were 15% (95% CI 4-42%) for MZ twin pairs and 18% (95% CI 5-48%) for DZ twin pairs (P = 0.53). The probandwise concordance rates were 27% (95% CI 11-52%) for MZ twin pairs and 31% (95% CI 13-58%) for DZ twin pairs (P = 0.40). Concordant rates resulted in MZ/DZ ratios of 0.83 for the pairwise analysis and 0.87 for the probandwise analysis (Table 2) .
Discussion
Although a systematic literature search identified a substantial number of twin pairs with the VATER/ VACTERL association, it was necessary to exclude 69% (38/55) of these from further analysis. This was either because of a lack of information on phenotype, zygosity, or concordance or the presence of additional congenital anomalies or disorders incompatible with the spectrum of the VATER/VACTERL association. The remaining twin pairs were subjected to a classic twin analysis, which showed almost equal pairwise and probandwise concordance rates for DZ and MZ twin pairs. Although this conservative approach reduced the number of patients available for analysis, such an approach is necessary in any study focusing on potentially heterogeneous conditions with a large differential diagnosis if valid results are to be obtained.
The present observation suggests that inherited genetic factors do not play a major role in the majority of VATER/ VACTERL association cases. Instead, environmental factors, postzygotic somatic or de-novo germline mutations (Kondo et al., 2002) , or epigenetic events occurring early in embryogenesis (Yamazawa et al., 2008 ) may be implicated. The application of new genomic technologies such as high-resolution copy number variation studies or next-generation exome sequencing in future studies should lead to the identification of some of these causes.
No environmental risk factors such as maternal diabetes, uterine vascular pathology, and inferitlity treatment were reported in the pregnancies of the MZ discordant twin pairs ascertained through our centers. However, this information was not recorded for the MZ discordant twin pairs identified through our literature review, and thus the presence of these risk factors in these cases cannot be excluded.
Few classical twin studies of rare congenital malformations have been reported to date, and thus experience in Twin study of the VATER/VACTERL association Bartels et al. 193 the interpretation of such results is limited. As in all twin studies that rely on case reports from the literature, potential biases may have impacted on the present results. These include underascertainment of diseasediscordant DZ twin pairs (Hamilton and Mack, 2000) and underascertainment of individuals whose co-twins had died (Hay and Wehrung, 1970) . Prospective populationbased ascertainment of twins is the ideal approach. However, given the rarity of the VATER/VACTERL association, the ascertainment of a sufficient number of affected twins would require a systematic surveillance of very large populations. Furthermore, the clinical phenotypes of patients with VATER/VACTERL association are often poorly delineated. This is mainly because of the imprecise phenotypic definition, and leads to the risk of the inadvertent inclusion of cases with a syndromic diagnosis (Shaw-Smith, 2006) . Hence, phenotypic evaluation of twin pairs ascertained through the literature has been restricted by the limited availabity of detailed information. Thus, affected twins with underlying syndromes that may overlap or resemble the VATER/ VACTERL association, for example Feingold syndrome, CHARGE syndrome, 22q11 deletion syndrome, etc., may have been among the cases from the literature and this may have influenced the results of our analysis.
Given the small number of twin pairs analyzed, our analysis and the generalizibility of the results are limited.
Conclusion
To our knowledge, the present study is the first to have used the twin method to assess the contribution of genetic factors to the VATER/VACTERL association. Although based on a limited number of twin pairs, our findings are consistent with the low number of familial observations reported to date, and suggest that the role of inherited genetic factors in the etiology of VATER/ VACTERL cases is limited. However, given the small sample size, our findings should be interpreted with caution.
